Related Experiment Video
Updated: Sep 10, 2025
06:04
Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
471
Clinical Adaptation of the Minimum Speech Test Battery-Version 3
Heather L Strader1, Camille C Dunn1,2, Teresa A Zwolan3
1Institute for Cochlear Implant Training, Saint Petersburg, FL.
American Journal of Audiology
|August 19, 2025
Summary
The Minimum Speech Test Battery-Version 3 (MSTB-3) is being adopted by audiologists for cochlear implant (CI) evaluations, improving consistency. Further training is recommended to maximize its benefits for patient care.
Area of Science:
- Audiology
- Otolaryngology
- Medical Devices
Background:
- The Minimum Speech Test Battery-Version 3 (MSTB-3) was introduced in 2024.
- It is an evidence-based, streamlined test battery for adult cochlear implant (CI) candidacy and performance assessment.
Purpose of the Study:
- To examine audiologists' understanding and adoption of the MSTB-3.
- To gather clinical insights on the implementation of the MSTB-3 protocol.
Main Methods:
- A 32-question survey was distributed to 307 audiologists via email and social media.
- The survey assessed familiarity, training, and integration of MSTB-3 recommendations.
- Descriptive statistics were used for data analysis.
Main Results:
- 89% of audiologists are familiar with the MSTB-3; 60% have undergone training.
- 85% incorporate MSTB-3 recommendations into practice, with 75% noting improved standardization.
- Clinicians use Consonant-Nucleus-Consonant (CNC) word scores for candidacy but show variability in criteria.
Conclusions:
- The MSTB-3 enhances consistency in CI evaluation and follow-up care.
- Its evidence-based, streamlined approach improves CI access and standardization.
- Further training and dissemination are recommended to address challenges and reduce disparities.
